Iroko Pharmaceuticals

81 articles about Iroko Pharmaceuticals

• Egalet Signs Asset Purchase Agreement to Acquire Four FDA-Approved, Non-Narcotic Pain Products

  10/31/2018

  Anticipates projected pro forma annual net revenue of between $80 and $90 million.

• Philadelphia Drugmaker Iroko Pharma Pink Slips Another 122 Employees

  6/5/2017

• Iroko Pharma Announces Key Patent For VIVLODEX

  1/6/2017

• Iroko Pharma Provides Update In Relation To Zorvolex

  12/7/2016

• Iroko Pharma Slashes a Quarter of Workforce, But Plans to Hire 90 Sales Reps

  9/21/2016

• Iroko Pharmaceuticals Secures Debt Financing From CRG

  6/29/2016

• Iroko Pharmaceuticals Summarizes Low-Dose SoluMatrix NSAID Efficacy And Safety Data At American Association Of Nurse Practitioners National Conference

  6/23/2016

• Iroko Pharmaceuticals Release: New Data Shows That VIVLODEX Reduces Rescue Medication Use In Patients With Osteoarthritis Pain

  5/12/2016

• Iroko Pharmaceuticals Release: Survey Finds 8 In 10 Americans Experience Different Forms Of Pain But Many Are Unable To Effectively Control It

  4/7/2016

• Iroko Pharmaceuticals To Present Phase 3 VIVLODEX Efficacy And Safety Data At World Congress Of Osteoarthritis

  3/31/2016

• Iroko Pharmaceuticals Release: VIVLODEX Now Available In U.S. Pharmacies For The Management Of Osteoarthritis Pain

  2/16/2016

• Iroko Pharmaceuticals Receives FDA Approval For VIVLODEX - First Low Dose SoluMatrix Meloxicam For Osteoarthritis Pain

  10/23/2015

• Iroko Pharmaceuticals Announces Eighth International Licensing Agreement For ZORVOLEX

  7/15/2015

• Iroko Pharmaceuticals Release: TIVORBEX Now Available In U.S. Pharmacies For The Treatment Of Acute Pain

  6/29/2015

• Iroko Pharmaceuticals Announces First International Launch Of ZORVOLEX

  5/14/2015

• Iroko Pharmaceuticals Announces Additional International Licensing Agreement For ZORVOLEX

  5/6/2015

• Iroko Pharmaceuticals Granted New Patent For ZORVOLEX

  4/29/2015

• Iroko Pharmaceuticals Appoints New Member To Company’s Board Of Directors

  4/1/2015

• Iroko Pharmaceuticals Announces Acceptance Of U.S. Filing For Solumatrix Meloxicam In Osteoarthritis Pain

  3/12/2015

• Iroko Pharmaceuticals Announces International Regulatory Approval For ZORVOLEX®

  12/10/2014